Proxy Votes Now

Home › Activist investors › Hudson Executive

Hudson Executive

Campaign activist. Positions and campaigns from Hudson Executive’s SEC filings. Updated November 20, 2026.

Filer entities
Hudson Executive Capital LP
SEC CIK
1652522 (Hudson Executive Capital LP)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Jun 30, 2026, filed Aug 14, 2026: 1 US-listed positions reported; 0 of 1% or more of a company without a 13D are listed below.
0current positions
0new or changed in 90 days
0active campaigns
3campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (0)

No current position by this definition.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (3)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
ViewRay, Inc. Stake reported below 5% Jul 21, 2023 Feb 24, 2020 — latest (4) —
eHealth, Inc. Settled (agreement with the company) Mar 11, 2021 Feb 19, 2021 — latest (4) —
Cantaloupe, Inc.Board seats No campaign filings in the last 12 months Apr 20, 2020 May 20, 2019 Proxy contest filed latest (32) —
Past positions (3)
CompanyLast stakeSourceOutcomeDate
Talkspace, Inc. 0.0% Schedule 13D/A, filed Aug 17, 2026 Exited Aug 17, 2026
Cantaloupe, Inc. 12.8% Schedule 13D/A, filed Jun 16, 2025 Not in the 13F for the quarter ended Jun 30, 2026 Aug 14, 2026
ViewRay, Inc. 3.7% Schedule 13D/A, filed Jul 21, 2023 Reported below 5% in a 13D/A Jul 21, 2023

How large managers voted in Hudson Executive’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

2Settlement
1No outcome in the filings read
Outcome of each campaign (3)
CompanyOutcomeDetailDateFirst filing
ViewRay, Inc. Settlement agreement with the company Jan 20, 2023 Feb 24, 2020
eHealth, Inc. Settlement agreement with the company Jun 7, 2021 Feb 19, 2021
Cantaloupe, Inc. No outcome in the filings read — Apr 20, 2020 May 20, 2019

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 3 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Settlement terms

Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.

ViewRay, Inc. · Jan 20, 2023 · Directors named, Ownership cap, Voting commitment

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Hudson Executive’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Talkspace, Inc. · Hudson Executive first disclosed Mar 10, 2026 · 4 other filings
HolderFormDateStake
BlackRock, Inc. Schedule 13G Oct 17, 2025 5.4%
MAK Capital Fund LP Schedule 13G Mar 2, 2026 5.2%
Barclays PLC Schedule 13G May 14, 2026 6.1%
Balyasny Asset Management L.P. Schedule 13G May 15, 2026 5.3%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.